Structure and function of S-adenosylhomocysteine hydrolase

被引:157
作者
Turner, MA
Yang, XD
Yin, D
Kuczera, K
Borchardt, RT
Howell, PL
机构
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[3] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA
[4] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA
[5] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada
关键词
adenosine (Ado); ado kinase(AK); homocysteine (Hcy); neplanocin A (Nep A); S-adenosylhomocysteine (AdoHcy); S-adenosylhomocysteine hydrolase (AdoHcyase); transmethylations;
D O I
10.1385/CBB:33:2:101
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In mammals, S-adenosylhomocysteine hydrolase (AdoHcyase) is the only known enzyme to catalyze the breakdown of S-adenosylhomocysteine (AdoHcy) to homocysteine and adenosine. AdoHcy is the product of all adenosylmethionine (AdoMet)-dependent biological transmethylations. These reactions have a wide range of products, and are common in all facets of biometabolism. As a product inhibitor, elevated levels of AdoHcy suppress AdoMet-dependent transmethylations. Thus, AdoHcyase is a regulator of biological transmethylation in general. The three-dimensional structure of AdoHcyase complexed with reduced nicotinamide adenine dinucleotide phosphate (NADH) and the inhibitor (1'R, 2'5, 3'R)-9- (2',3'-dihyroxycydopenten-1-yl)adenine (DHCeA) was solved by a combination of the crystallographic direct methods program, SnB, to determine the selenium atom substructure and by treating the multiwavelength anomalous diffraction data as a special case of multiple isomorphous replacement. The enzyme architecture resembles that observed for NAD-dependent dehydrogenases, with the catalytic domain and the cofactor-binding domain each containing a modified Rossmann fold. The two domains form a deep active site cleft containing the cofactor and bound inhibitor molecule. A comparison of the inhibitor complex of the human enzyme and the structure of the rat enzyme, solved without inhibitor, suggests that a 17 degrees rigid body movement of the catalytic domain occurs upon inhibitor/substrate binding.
引用
收藏
页码:101 / 125
页数:25
相关论文
共 107 条
[31]   BROAD-SPECTRUM ANTIVIRAL ACTIVITIES OF NEPLANOCIN-A, 3-DEAZANEPLANOCIN-A, AND THEIR 5'-NOR DERIVATIVES [J].
DECLERCQ, E ;
COOLS, M ;
BALZARINI, J ;
MARQUEZ, VE ;
BORCHERDING, DR ;
BORCHARDT, RT ;
DRACH, JC ;
KITAOKA, S ;
KONNO, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1291-1297
[32]   ALKYL ESTERS OF 3-ADENIN-9-YL-2-HYDROXYPROPANOIC ACID - A NEW CLASS OF BROAD-SPECTRUM ANTIVIRAL AGENTS [J].
DECLERCQ, E ;
HOLY, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (03) :282-287
[33]   Trypanosomal nucleoside hydrolase. A novel mechanism from the structure with a transition-state inhibitor [J].
Degano, M ;
Almo, SC ;
Sacchettini, JC ;
Schramm, VL .
BIOCHEMISTRY, 1998, 37 (18) :6277-6285
[34]   Three-dimensional structure of the inosine-uridine nucleoside N-ribohydrolase from Crithidia fasciculata [J].
Degano, M ;
Gopaul, DN ;
Scapin, G ;
Schramm, VL ;
Sacchettini, JC .
BIOCHEMISTRY, 1996, 35 (19) :5971-5981
[35]  
DELAHABA G, 1959, J BIOL CHEM, V234, P603
[36]  
FREISTADT MS, 1988, J BIOL CHEM, V263, P15071
[37]  
FUJIOKA M, 1981, J BIOL CHEM, V256, P1631
[38]  
GLAZER RI, 1984, J BIOL CHEM, V259, P2964
[39]   3-DEAZANEPLANOCIN-A - A NEW INHIBITOR OF S-ADENOSYLHOMOCYSTEINE SYNTHESIS AND ITS EFFECTS IN HUMAN-COLON CARCINOMA-CELLS [J].
GLAZER, RI ;
KNODE, MC ;
TSENG, CKH ;
HAINES, DR ;
MARQUEZ, VE .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (24) :4523-4527
[40]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781